Highlights
NASDAQ: CRTX       Cortexyme Inc
Last Price Today's Change   Day's Range   Trading Volume
39.05   +3.87 (11.00%)  34.50 - 39.15  242,700

Overview

 
Avg Volume (4 weeks):187,031
4 Weeks Range:23.00 - 39.15
4 Weeks Price Volatility (%):
99.38%
52 Weeks Range:19.35 - 47.50
52 Weeks Price Volatility (%):
69.98%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cornerstone Therapeutics Inc. is a specialty pharmaceutical company focused on commercializing products for the hospital, respiratory and related specialty markets. The Company's promoted products include CUROSURF, ZYFLO CR, FACTIVE and SPECTRACEF. On December 30, 2011, the Company acquired Cardiokine, Inc., a specialty pharmaceutical company, focused on developing hospital products for cardiovascular indications. In March 2012, it acquired the North American product rights for FACTIVE (Gemifloxacin Mesylate) tablets. In June 2012, the Company acquired EKR Therapeutics, Inc. In February 2014, Chiesi Farmaceutici S.p.A acquired Cornerstone Therapeutics Inc.

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers